Theravance Biopharma, Inc. Effective Tax Rate
Theravance Biopharma, Inc. (TBPH) reported Effective Tax Rate of 18.07% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-03-23
- Theravance Biopharma, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 18.07%.
- Theravance Biopharma, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was -26.46%, a 320.13% decline from fiscal 2023.
- Theravance Biopharma, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 12.02%.
- Theravance Biopharma, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was -0.01%, a 116.67% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 12 month | Effective Income Tax Rate Reconciliation, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 18.07% 10-K · filed 2026-03-23 | |
| 2024-12-31 | -26.46% 10-K · filed 2026-03-23 | 26.46% 10-K · filed 2025-03-07 |
| 2023-12-31 | 12.02% 10-K · filed 2025-03-07 | |
| 2022-12-31 | -0.01% 10-K · filed 2024-03-01 | |
| 2021-12-31 | 0.06% 10-K · filed 2023-03-01 | 0.08% 10-K · filed 2022-02-28 |
| 2020-12-31 | 2.81% 10-K · filed 2023-03-01 | 2.97% 10-K · filed 2021-02-26 |
| 2019-12-31 | 2.16% 10-K · filed 2022-02-28 | |
| 2018-12-31 | 4.67% 10-K · filed 2021-02-26 | |
| 2017-12-31 | -5.04% 10-K · filed 2020-02-27 | |
| 2016-12-31 | -5.60% 10-K · filed 2019-02-28 | |
| 2015-12-31 | -0.52% 10-K · filed 2018-02-28 | |
| 2014-12-31 | -2.76% 10-K · filed 2017-03-01 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-11 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |